New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 11 states.
Cannabis sales decreased by 0.8% in June compared to May cannabis data analytics firm BDSA. Looking at a per-day basis, sales increased across all 11 states month-over-month. Compared to a year ago, sales were down in 7 markets, mostly driven by declining flower growth. In this review, we will look at the markets one-by-one, starting with the eastern markets and then concluding with the western markets. In total, sales across the 11 markets totaled $1.65 billion during the month.
BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan and Pennsylvania. In June, year-over-year growth ranged from -9% in Maryland to 23.5% in Florida and Michigan. Note that Florida, Maryland and Pennsylvania are medical-only markets.
In June, sales increased 3.2% sequentially to $192.4 million, up 23.5% from a year ago. Flower sales grew 20%, pre-rolls increased 13%, ingestibles gained 14% and concentrates expanded 37% year-over-year.
We previously published data released by the state showing that sales declined 3% from May and increased 5.4% from June 2021. BDSA estimated sales of $155.3 million, down 2.9% sequentially and up 5.4% from a year ago. Compared to last year, flower sales remained flat, pre-rolls jumped 36%, ingestibles grew 2% and concentrates increased 8%.
Sales fell 3% from May to $41 million, down 9% from a year ago. Flower sales decreased 10%, pre-rolls declined 9% and concentrates fell 13%, while ingestibles grew 6% year-over-year.
Sales grew 0.9% sequentially and 9.4% compared to a year ago to $145.4 million. Flower sales expanded 2%, pre-rolls expanded 29%, ingestibles increased 11% and concentrates grew 10%.
We had previously written about data released by the state indicating that Michigan cannabis sales gained 0.5% sequentially and 26% year-over-year. BDSA estimated sales of $187.4 million, up 0.5% sequentially and 23.5% from a year ago. Flower sales increased 16%, while concentrates grew 49%. Pre-rolls jumped 64% and ingestibles remained flat compared to the previous year.
Sales fell 1.6% in June to $94.8 million, down 7.6% compared to a year ago. Flower sales declined 5% year-over-year, concentrates fell 11%, while ingestibles decreased 3%.
BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In June, year-over-year growth ranged from -20.6% in Colorado to -5.1% in California compared to a year ago.
Combined sales of $106 million were down 2.7% from May and 10.1% compared to June 2021. Medical sales of $42.8 million were down 8% sequentially and 33% from a year ago. Adult-use sales of $63.1 million gained 1% from May and 18% year-over-year. Flower sales were down 24% from a year ago, while pre-rolls grew 35%. Concentrates fell 6% and ingestibles gained 6%.
California sales declined 2.5% sequentially to $431.3 million and fell 5.1% compared to a year ago. Flower sales were down 15%, while pre-rolls grew 12%. Ingestibles fell 4% and concentrates remained flat from a year ago during June.
Sales increased 0.6% in June compared to May, dropping 20.6% from a year ago to $148.8 million. Flower sales were down 24%, with pre-rolls and concentrates falling 16%. Ingestibles declined 22% year-over-year.
Sales increased 1.7% sequentially, falling 18.9% from a year ago to $66.4 million. Flower sales dropped 30% from a year ago. Concentrates fell 3%, while ingestibles decreased 12% and pre-rolls declined 15%.
Sales in June fell 2.3% from May to $82.7 million, down 17% from a year ago. Flower sales were down 30% year-over-year. Ingestibles grew 11%, while pre-rolls declined 5% and concentrates decreased 14%.
For readers interested in a deeper look at cannabis markets across these eleven states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how BDSA Solutions can provide you with unlimited access to the most accurate and actionable data and analysis.